REFERENCES:
Angiogenesis inhibitors. National Cancer Institute website. Available at: http://www.cancer.gov/about-cancer/treatment/types/immunotherapy/angiogenesis-inhibitors-fact-sheet. Updated October 7, 2011. Accessed September 25, 2014.
Biological therapies for cancer. National Cancer Institute website. Available at: http://www.cancer.gov/about-cancer/treatment/types/immunotherapy/bio-therapies-fact-sheet. Updated June 12, 2013. Accessed September 25, 2014.
Chemotherapy and targeted therapy. Texas Oncology website. Available at: http://www.texasoncology.com/types-of-cancer/prostate-cancer/targeted-therapy-for-prostate-cancer. Accessed September 25, 2014.
Enzalutamide. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed. Updated August 25, 2014. Accessed September 25, 2014.
Evolution of cancer treatments: targeted therapy. American Cancer Society website. Available at: http://www.cancer.org/cancer/cancerbasics/thehistoryofcancer/the-history-of-cancer-cancer-treatment-targeted-therapy. Updated June 12, 2014. Accessed September 25, 2014.
FDA approval for sipuleucel-T. National Cancer Institute website. Available at: http://www.cancer.gov/cancertopics/druginfo/fda-sipuleucel-T. Updated July 3, 2013. Accessed September 25, 2014.
Imatinib. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed. Updated September 1, 2014. Accessed September 25, 2014.
Prostate cancer. American Cancer Society website. Available at: http://www.cancer.org/acs/groups/cid/documents/webcontent/003134-pdf.pdf. Accessed September 25, 2014.
Prostate cancer. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed. Updated July 10, 2014. Accessed September 25, 2014.
Prostate cancer screening. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed. Updated April 4, 2014. Accessed September 25, 2014.
Prostate cancer staging and imaging. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed. Updated September 1, 2014. Accessed September 25, 2014.
What is provenge immunotherapy? Provenge website. Available at: http://www.provenge.com/advanced-prostate-cancer-immunotherapy.aspx Accessed July 31, 2012.
2/12/2010 DynaMed's Systematic Literature Surveillance http://www.ebscohost.com/dynamed: Smith DP, King MT, Egger S, et al. Quality of life three years after diagnosis of localised prostate cancer: population based cohort study. BMJ. 2009;339:b4817.
2/19/2010 DynaMed's Systematic Literature Surveillance http://www.ebscohost.com/dynamed: Mahmud SM, Franco EL, Aprikian AG. Use of non-steroidal anti-inflammatory drugs (NSAIDs) and prostate cancer risk: a meta-analysis. Int J Cancer. 2010;127(7):1680-1691.
Ultima revisión September 2020 por
EBSCO Medical Review Board
Mohei Abouzied, MD, FACP Last Updated: 09/08/2020